Home » Topics » Regulatory

Regulatory
RSS

EC first to approve Crysvita for treatment of X-linked hypophosphatemia

Feb. 26, 2018

Xofluza approved in Japan for treatment of influenza types A and B

Feb. 23, 2018

FDA approves Imfinzi for unresectable stage III NSCLC

Feb. 19, 2018

Gilead Sciences' Harvoni approved for new indication in Japan

Feb. 19, 2018

FDA approves Erleada for non-metastatic castration-resistant prostate cancer

Feb. 15, 2018

FDA approves Symdeko to treat underlying cause of cystic fibrosis

Feb. 13, 2018

FDA approves Biktarvy to treat HIV-1 infection

Feb. 8, 2018

FDA approves Synergy Pharmaceuticals' Trulance for IBS-C

Jan. 26, 2018

EC extends approval of Adcetris to include cutaneous T-cell lymphoma

Jan. 23, 2018

Nailin approved in Japan for onychomycosis

Jan. 23, 2018